• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医治疗2型糖尿病中药的模块化特征及作用机制

Modular characteristics and mechanism of action of herbs for type 2 diabetes treatment in Chinese medicine.

作者信息

Yang Chan, Liu Hanyu, Li Xinqiong, Peng Xi, Rao Guocheng, Xie Ziyan, Yang Qiangfei, Du Lian, Xie Chunguang

机构信息

Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, Sichuan, China.

Hospital of Chengdu University of Traditional Chinese Medicine, TCM regulating metabolic diseases key Laboratory of Sichuan province, 610075, Sichuan, Chengdu, China.

出版信息

Heliyon. 2023 Sep 16;9(9):e20106. doi: 10.1016/j.heliyon.2023.e20106. eCollection 2023 Sep.

DOI:10.1016/j.heliyon.2023.e20106
PMID:37809579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10559873/
Abstract

Type 2 diabetes (T2D) has emerged as a global epidemic, and conventional treatment approaches often face limitations in achieving long-term glycemic control and preventing complications. Traditional Chinese Medicine (TCM) offers a valuable alternative for managing T2D, with a long history of effectively using herbal formulations in clinical practice. However, the modular characteristics of these herbs and their specific mechanisms of action remain poorly understood. To comprehensively investigate the modular characteristics and mechanisms of Chinese herbs in treating T2D, as well as explore the synergistic interactions among different herbs and their modular components, we employed data mining, systematic pharmacology, and molecular docking. Our aim was to gain a comprehensive understanding of the potential therapeutic targets and pathways involved in herbal T2D treatment. In this study, a total of 1114 studies investigating the effects of TCM interventions in the treatment of T2D in adults were included. The analysis revealed 170 distinct types of Chinese herbs, 118 active components, and 238 common targets shared between the medicine and T2D. Additionally, this study identified six hub proteins (TNF, MMP2, PTGS, CASP3, CASP8, and CASP9) and two key chemicals (Diosgenin and Formononetin) found in TCM-mediated T2D suppression. It was observed that these proteins could bind with the ingredients. The MMP2-Diosgenin interaction exhibited the lowest binding free energy (-13.05 kJ/mol) and was primarily driven by hydrogen bonds with ALA-165. TNF-Diosgenin (-10.5 kcal/mol) showed three hydrogen bonds with LEU-37, ARG-82, and ASN-30. PTGS2 and Diosgenin (-8.71 kJ/mol) demonstrated a hydrogen bond with HIS-214. Furthermore, CASP9-Formononetin (-6.53 kcal/mol) exhibited the lowest binding free energy and hydrogen bonds with GLU-261 and SER-339 as the primary forces involved. CASP3-Formononetin (-6.07 kcal/mol) displayed three hydrogen bonds with ASN-342, TRP-348, and GLU-379. Lastly, CASP8 and Formononetin (-6.06 kJ/mol) formed a hydrogen bond with THR-390, TYR-392, and TYR-334. Moreover, critical therapeutic pathways, such as the immune inflammatory response, AGE-RAGE, and IL-17 signaling pathway, were found to be associated with T2D Chinese herb therapy. In conclusion, this study sheded light on the modular characteristics and mechanism of action of herbs used in Chinese Medicine for the treatment of T2D, which provided valuable insights for both researchers and practitioners in the field of Chinese Medicine, offering potential avenues for improved treatment strategies and personalized approaches to address the complex nature of T2D.

摘要

2型糖尿病(T2D)已成为一种全球流行病,传统治疗方法在实现长期血糖控制和预防并发症方面常常面临局限性。中医为T2D的管理提供了一种有价值的替代方法,在临床实践中有效使用草药配方有着悠久的历史。然而,这些草药的模块化特征及其具体作用机制仍知之甚少。为了全面研究中药治疗T2D的模块化特征和机制,并探索不同草药及其模块化成分之间的协同相互作用,我们采用了数据挖掘、系统药理学和分子对接方法。我们的目的是全面了解草药治疗T2D所涉及的潜在治疗靶点和途径。在本研究中,共纳入了1114项调查中医干预对成人T2D治疗效果的研究。分析揭示了170种不同类型的中药、118种活性成分以及药物与T2D之间共有的238个常见靶点。此外,本研究确定了在中医介导的T2D抑制中发现的六种枢纽蛋白(TNF、MMP2、PTGS、CASP3、CASP8和CASP9)和两种关键化学物质(薯蓣皂苷元和芒柄花素)。观察到这些蛋白质可以与这些成分结合。MMP2 - 薯蓣皂苷元相互作用表现出最低的结合自由能(-13.05 kJ/mol),主要由与ALA - 165的氢键驱动。TNF - 薯蓣皂苷元(-10.5 kcal/mol)与LEU - 37、ARG - 82和ASN - 30形成了三个氢键。PTGS2和薯蓣皂苷元(-8.71 kJ/mol)与HIS - 214形成了一个氢键。此外,CASP9 - 芒柄花素(-6.53 kcal/mol)表现出最低的结合自由能,与GLU - 261和SER - 339的氢键是主要作用力。CASP3 - 芒柄花素(-6.07 kcal/mol)与ASN - 342、TRP - 348和GLU - 379形成了三个氢键。最后,CASP8和芒柄花素(-6.06 kJ/mol)与THR - 390、TYR - 392和TYR - 334形成了一个氢键。此外,还发现关键治疗途径,如免疫炎症反应、AGE - RAGE和IL - 17信号通路与中医治疗T2D有关。总之,本研究揭示了用于治疗T2D的中药的模块化特征和作用机制,为中医领域的研究人员和从业者提供了有价值的见解,为改进治疗策略和个性化方法以应对T2D的复杂性提供了潜在途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/e77c43e91093/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/b14f9cfc2b72/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/cdde29d20994/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/4aed36657e2a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/a962c74ac453/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/bb55da2382a3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/97b7f5f31c74/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/eb71f61a0539/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/c07991904387/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/e77c43e91093/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/b14f9cfc2b72/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/cdde29d20994/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/4aed36657e2a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/a962c74ac453/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/bb55da2382a3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/97b7f5f31c74/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/eb71f61a0539/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/c07991904387/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de51/10559873/e77c43e91093/gr9.jpg

相似文献

1
Modular characteristics and mechanism of action of herbs for type 2 diabetes treatment in Chinese medicine.中医治疗2型糖尿病中药的模块化特征及作用机制
Heliyon. 2023 Sep 16;9(9):e20106. doi: 10.1016/j.heliyon.2023.e20106. eCollection 2023 Sep.
2
Modular characteristics and mechanism of action of herbs for vascular calcification treatment in Chinese medicine: a data mining and network pharmacology-based identification.中药治疗血管钙化的草药模块化特征及作用机制:基于数据挖掘和网络药理学的识别
Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):1774-1792. doi: 10.26355/eurrev_202303_31539.
3
An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms.一种优化的治疗肝纤维化的草药组合:关键基因、生物活性成分和分子机制。
J Ethnopharmacol. 2022 Oct 28;297:115567. doi: 10.1016/j.jep.2022.115567. Epub 2022 Jul 20.
4
Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.用于治疗骨质疏松症的中药方剂:对抗骨质疏松药物发现的启示。
J Ethnopharmacol. 2016 Aug 2;189:61-80. doi: 10.1016/j.jep.2016.05.025. Epub 2016 May 11.
5
Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining.基于网络药理学和数据挖掘对新型冠状病毒肺炎继发肺纤维化的分子机制及高频核心中药进行研究
Ann Palliat Med. 2021 Apr;10(4):3960-3975. doi: 10.21037/apm-20-1384. Epub 2021 Apr 1.
6
Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology-Based Identification.基于数据挖掘与网络药理学的中医治疗子宫内膜异位症用药的模块化特征及作用机制研究
Front Pharmacol. 2020 Mar 6;11:147. doi: 10.3389/fphar.2020.00147. eCollection 2020.
7
[Study on relevance mining of "core drug action target" in Dictionary of Traditional Chinese Medicine Prescriptions].[《中医方剂大辞典》中“核心药物作用靶点”关联挖掘研究]
Zhongguo Zhong Yao Za Zhi. 2018 Oct;43(19):3919-3926. doi: 10.19540/j.cnki.cjcmm.20180710.002.
8
Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.运用网络药理学、分子对接和分子动力学模拟探究茵陈五苓散治疗高脂血症的作用机制。
Biomed Res Int. 2021 Oct 28;2021:9965906. doi: 10.1155/2021/9965906. eCollection 2021.
9
Investigation of the Mechanism of Traditional Chinese Medicines in Angiogenesis through Network Pharmacology and Data Mining.基于网络药理学和数据挖掘的中药血管生成机制研究
Evid Based Complement Alternat Med. 2021 Apr 28;2021:5539970. doi: 10.1155/2021/5539970. eCollection 2021.
10
Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas.基于中药方剂临床疗效的潜在哮喘靶点的发现。
J Ethnopharmacol. 2020 Apr 24;252:112635. doi: 10.1016/j.jep.2020.112635. Epub 2020 Jan 28.

引用本文的文献

1
Network Pharmacology Analysis, Molecular Docking Integrated Experimental Verification Reveal the Mechanism of in the Treatment of Type II Diabetes by Regulating the IRS1/PI3K/Akt Signaling Pathway.网络药理学分析、分子对接结合实验验证揭示[具体药物名称未给出]通过调节IRS1/PI3K/Akt信号通路治疗2型糖尿病的机制。
Curr Issues Mol Biol. 2024 Jun 1;46(6):5561-5581. doi: 10.3390/cimb46060333.

本文引用的文献

1
Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics.基于临床转录组学探讨降糖调脂方对肥胖 2 型糖尿病合并血脂异常的生物网络调控作用。
Front Endocrinol (Lausanne). 2022 Jul 25;13:817147. doi: 10.3389/fendo.2022.817147. eCollection 2022.
2
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials.聚焦于芒柄花黄素:其神经保护潜力的最新观点。
Front Pharmacol. 2022 May 30;13:905898. doi: 10.3389/fphar.2022.905898. eCollection 2022.
3
Inflammation in obesity, diabetes, and related disorders.
肥胖、糖尿病及相关紊乱中的炎症。
Immunity. 2022 Jan 11;55(1):31-55. doi: 10.1016/j.immuni.2021.12.013.
4
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022.8. 肥胖与体重管理以预防和治疗 2 型糖尿病:2022 年糖尿病医学诊疗标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S113-S124. doi: 10.2337/dc22-S008.
5
Pi-Dan-Jian-Qing Decoction Ameliorates Type 2 Diabetes Mellitus Through Regulating the Gut Microbiota and Serum Metabolism.砒丹煎清汤通过调节肠道微生物群和血清代谢改善 2 型糖尿病。
Front Cell Infect Microbiol. 2021 Dec 6;11:748872. doi: 10.3389/fcimb.2021.748872. eCollection 2021.
6
Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian Decoction from the perspective of exosomal miRNA.从外泌体 miRNA 的角度探讨 2 型糖尿病肠道湿热证的发病机制及葛根芩连汤的治疗作用。
J Ethnopharmacol. 2022 Mar 1;285:114786. doi: 10.1016/j.jep.2021.114786. Epub 2021 Nov 8.
7
The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial.中药金芪降糖颗粒对新诊断 2 型糖尿病患者血糖变异性的影响:一项双盲、随机试验。
J Diabetes Res. 2021 Oct 8;2021:6303063. doi: 10.1155/2021/6303063. eCollection 2021.
8
An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective.2 型糖尿病流行病学的最新进展:全球视角。
Endocrinol Metab Clin North Am. 2021 Sep;50(3):337-355. doi: 10.1016/j.ecl.2021.05.013.
9
Emerging Targets in Type 2 Diabetes and Diabetic Complications.2 型糖尿病及糖尿病并发症的新兴靶点。
Adv Sci (Weinh). 2021 Sep;8(18):e2100275. doi: 10.1002/advs.202100275. Epub 2021 Jul 28.
10
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes.2 型糖尿病的治疗:挑战、希望和预期的成功。
Lancet Diabetes Endocrinol. 2021 Aug;9(8):525-544. doi: 10.1016/S2213-8587(21)00113-3. Epub 2021 Jun 25.